Andrew Obenshain
Directeur Général chez BLUEBIRD BIO, INC.
Fortune : 255 638 $ au 30/04/2024
Postes actifs de Andrew Obenshain
Sociétés | Poste | Début | Fin |
---|---|---|---|
BLUEBIRD BIO, INC. | Directeur/Membre du Conseil | 04/11/2021 | - |
Directeur Général | 04/11/2021 | - | |
President | 04/11/2021 | - | |
Corporate Officer/Principal | 01/01/2016 | 04/11/2021 | |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Directeur/Membre du Conseil | 30/03/2017 | - |
Historique de carrière de Andrew Obenshain
Anciens postes connus de Andrew Obenshain
Sociétés | Poste | Début | Fin |
---|---|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
Formation de Andrew Obenshain
Kellogg School of Management | Masters Business Admin |
Dartmouth College | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Royaume-Uni | 2 |
France | 2 |
Opérationnelle
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BLUEBIRD BIO, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
- Bourse
- Insiders
- Andrew Obenshain
- Expérience